Lido Advisors
ARKG icon

Lido Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Lido Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-400
Closed -$11.3K – 1153
2022
Q4 		$11.3K Buy
+400
New +$12.7K ﹤0.01% 1015

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Lido Advisors's ARKG Position: Q2 2023 in Review

Lido Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2023, closing a stake of 6,887 shares — an estimated $207K sold.

Lido Advisors first reported a position in ARKG in Q4 2019 and held it in 14 quarters. The position peaked at $7.89M in Q2 2021. 290 funds tracked by Wall St. Rank hold ARKG as of Q2 2023.

  • Lido Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2023 after selling out during the quarter.
  • Lido Advisors sold 6,887 ARK Genomic Revolution ETF shares in Q2 2023, an estimated $207K.
  • Lido Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 14 quarters.
  • Lido Advisors's ARK Genomic Revolution ETF position peaked at $7.89M in Q2 2021.
  • 290 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2023.

Based on Lido Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.